Researchers have demonstrated the potential of treating ovarian cancer using frankincense. The findings come from the lab, tested on cells and not actual live organisms, as greenmedinfo.com points out.
With so many natural substances showing huge potential in the lab, why is it so hard to set up clinical trials? Why is that when a pharmaceutical drug shows the same potential, clinical trials start right away?
advertisement - learn more
Like the Magi, carrying myrrh, frankincense, and gold, researchers from the University of Leicester have, for the first time, demonstrated the potential of treating ovarian cancer using the Christmas gift frankincense.
The origins of frankincense can be traced to the Arabian Peninsula. According to Herodotus (5th century BC):
“Arabia is the only country which produces frankincense, myrrh, cassia, and cinnamon.. the trees bearing the frankincense are guarded by winged serpents of small size and various colors. (See this GreenMedInfo Summary).”
Frankincense, along with gold and myrrh, is one of the most famous Christmas presents in history, and is a fragrant plant resin extracted from the Boswellia sacra tree found across Africa and Arabia. Using the compound AKBA (acetyl-11-keto-beta-boswellic acid) derived from the resin, the research has successfully shown its potential effectiveness in targeting ovarian cancer.
More specifically, they have been able to demonstrate the ability of AKBA to combat cancer cells in late-stage ovarian cancer.
advertisement - learn more
Lead researcher Kamla Al-Salmani, PhD student from the University’s Department of Cancer Studies and Molecular Medicine explained:
“After a year of studying the AKBA compound with ovarian cancer cell lines in vitro, we have been able to show it is effective at killing the cancer cells. Frankincense is taken by many people with no known side effects. This finding has enormous potential to be taken to a clinical trial in the future and developed into an additional treatment for ovarian cancer.”
Frankincense has been used as a folk medicine for centuries due to its anti-inflammatory properties, making it a viable treatment for asthma, skin conditions and gastroenteritis among others. Previous studies have also successfully linked AKBA as a potential treatment for many other cancers, including colon, breast and prostate cancer; however this is the first study to demonstrate its potential in combating ovarian cancer.
The researchers have shown that this frankincense compound is effective at killing ovarian cancer cells at realistic concentrations. What has been most surprising is that the cells we have tested which are resistant to chemotherapy have shown to be more sensitive to this compound, suggesting frankincense may indeed be able to help overcome drug resistance, and lead to an improved survival rate for patients with late-stage ovarian cancer.
Human bladder cancer cells and immortalized normal bladder cells were studied using Frankincense oil; Frankincense oil appears to distinguish cancerous from normal bladder cells and suppress cancer cell viabilityThis study compares Boswellia sacra essential oil hydrodistilled at 100 °C vs 78 °C in inducing cancer cell death in cultured breast cancer cells; the oil prepared at 100 °C was more potent in inducing breast cancer cell-specific cytotoxicityEssential oil hand massage was used with hospice patients with terminal cancer with a positive effect on pain and depressionBoswellia contains a compound (AKBA) which has inhibitory properties in meningioma cellsBoswellia contains a compound which suppresses proliferation and induces programmed cell death in meningioma cells
Ken McGowan is an environmentalist, social entrepreneur & the former leader of the Green Party of Nova Scotia.
Ken is a graduate of the U of T with a degree in molecular biology, and is the founder & product formulator of Sinfully Wholesome, a socially & environmentally responsible natural skin care company.